|
|
Volumn 52, Issue 2, 2001, Pages 213-215
|
|
Tacrolimus/cerivastatin interaction study in liver transplant recipients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CERIVASTATIN;
CYCLOSPORIN;
CYTOCHROME P450;
DRUG METABOLITE;
NYSTATIN;
PREDNISOLONE;
RANITIDINE;
STATIN;
TACROLIMUS;
ADULT;
AREA UNDER THE CURVE;
BLOOD PRESSURE;
BLOOD SAMPLING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG ACCUMULATION;
DRUG BLOOD LEVEL;
DRUG HALF LIFE;
DRUG SAFETY;
DRUG TOLERABILITY;
ELECTROCARDIOGRAM;
FEMALE;
FLUORESCENCE;
GEOMETRY;
HEART RATE;
HUMAN;
IMMUNOASSAY;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
LIQUID LIQUID EXTRACTION;
LIVER TRANSPLANTATION;
MALE;
MEASUREMENT;
PRIORITY JOURNAL;
STEADY STATE;
URINALYSIS;
ACYL COENZYME A;
ADULT;
CYCLOSPORINE;
CYTOCHROME P-450 ENZYME SYSTEM;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
FEMALE;
GRAFT REJECTION;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
PYRIDINES;
TACROLIMUS;
|
|
EID: 0034837361
PISSN: 03065251
EISSN: None
Source Type: Journal
DOI: 10.1046/j.0306-5251.2001.01424.x Document Type: Letter |
|
Times cited : (14)
|
|
References (17)
|
